PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BIS vs. NDAQ
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between BIS and NDAQ is -0.41. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.


-0.50.00.51.0-0.4

Performance

BIS vs. NDAQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares UltraShort Nasdaq Biotechnology (BIS) and Nasdaq, Inc. (NDAQ). The values are adjusted to include any dividend payments, if applicable.

0.00%500.00%1,000.00%JulyAugustSeptemberOctoberNovemberDecember
-99.60%
1,244.20%
BIS
NDAQ

Key characteristics

Sharpe Ratio

BIS:

-0.21

NDAQ:

2.31

Sortino Ratio

BIS:

-0.06

NDAQ:

3.21

Omega Ratio

BIS:

0.99

NDAQ:

1.41

Calmar Ratio

BIS:

-0.07

NDAQ:

2.22

Martin Ratio

BIS:

-0.38

NDAQ:

13.10

Ulcer Index

BIS:

19.62%

NDAQ:

3.27%

Daily Std Dev

BIS:

35.63%

NDAQ:

18.58%

Max Drawdown

BIS:

-99.77%

NDAQ:

-68.48%

Current Drawdown

BIS:

-99.71%

NDAQ:

-6.16%

Returns By Period

In the year-to-date period, BIS achieves a 4.00% return, which is significantly lower than NDAQ's 35.53% return. Over the past 10 years, BIS has underperformed NDAQ with an annualized return of -20.64%, while NDAQ has yielded a comparatively higher 18.84% annualized return.


BIS

YTD

4.00%

1M

4.82%

6M

10.56%

1Y

-4.31%

5Y*

-18.28%

10Y*

-20.64%

NDAQ

YTD

35.53%

1M

-2.68%

6M

29.77%

1Y

40.48%

5Y*

18.45%

10Y*

18.84%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BIS vs. NDAQ - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares UltraShort Nasdaq Biotechnology (BIS) and Nasdaq, Inc. (NDAQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BIS, currently valued at -0.21, compared to the broader market0.002.004.00-0.212.31
The chart of Sortino ratio for BIS, currently valued at -0.06, compared to the broader market-2.000.002.004.006.008.0010.00-0.063.21
The chart of Omega ratio for BIS, currently valued at 0.99, compared to the broader market0.501.001.502.002.503.000.991.41
The chart of Calmar ratio for BIS, currently valued at -0.07, compared to the broader market0.005.0010.0015.00-0.072.22
The chart of Martin ratio for BIS, currently valued at -0.38, compared to the broader market0.0020.0040.0060.0080.00100.00-0.3813.10
BIS
NDAQ

The current BIS Sharpe Ratio is -0.21, which is lower than the NDAQ Sharpe Ratio of 2.31. The chart below compares the historical Sharpe Ratios of BIS and NDAQ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
-0.21
2.31
BIS
NDAQ

Dividends

BIS vs. NDAQ - Dividend Comparison

BIS's dividend yield for the trailing twelve months is around 2.58%, more than NDAQ's 1.21% yield.


TTM20232022202120202019201820172016201520142013
BIS
ProShares UltraShort Nasdaq Biotechnology
2.58%1.75%0.00%0.00%0.44%2.10%0.37%0.00%0.00%0.00%0.00%0.00%
NDAQ
Nasdaq, Inc.
1.21%1.48%1.27%1.00%1.46%1.73%2.08%1.90%1.80%1.55%1.21%1.31%

Drawdowns

BIS vs. NDAQ - Drawdown Comparison

The maximum BIS drawdown since its inception was -99.77%, which is greater than NDAQ's maximum drawdown of -68.48%. Use the drawdown chart below to compare losses from any high point for BIS and NDAQ. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-99.71%
-6.16%
BIS
NDAQ

Volatility

BIS vs. NDAQ - Volatility Comparison

ProShares UltraShort Nasdaq Biotechnology (BIS) has a higher volatility of 11.55% compared to Nasdaq, Inc. (NDAQ) at 4.82%. This indicates that BIS's price experiences larger fluctuations and is considered to be riskier than NDAQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%JulyAugustSeptemberOctoberNovemberDecember
11.55%
4.82%
BIS
NDAQ
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab